School of Medicine
Showing 1,801-1,900 of 2,425 Results
-
Lisa Goldman Rosas
Associate Professor (Research) of Epidemiology and Population Health, of Medicine (Primary Care and Population Health) and, by courtesy, of Pediatrics
BioLisa Goldman Rosas, PhD MPH is an Associate Professor in the Department of Epidemiology and Population Health and the Department of Medicine, Division of Primary Care and Population Health at Stanford School of Medicine. An epidemiologist by training, Dr. Goldman Rosas’ research focuses on addressing disparities in diet-related chronic diseases such as diabetes, heart disease, depression, and cancer especially for those who face food insecurity. This research features rigorous quantitative and qualitative methodologies, participatory qualitative approaches, and shared leadership with patient and community partners. She is passionate about integrating patients, caregivers, community organizations, and other key stakeholders in the research process in order to affect the greatest improvements in health and well-being. As a reflection of this passion, Dr. Goldman Rosas serves as the Faculty Director for the School of Medicine Office of Community Engagement, Co-Director of Community-Engaged Research for the Office of Cancer Health Equity, and Director of the Outreach, Recruitment and Engagement Core for the Alzheimer's Disease Research Center. In these roles, she supports other faculty and patient and community partners to develop sustainable and meaningful partnerships to support transformative research. In addition to research, she teaches at the undergraduate and graduate levels and has a special focus on increasing capacity in community engagement methods.
-
Glenn Rosen
Associate Professor of Medicine (Pulmonary and Critical Care Medicine), Emeritus
Current Research and Scholarly InterestsOur laboratory examines apoptotic and cell signaling pathways in cancer and lung disease. We are studying signaling pathways that regulate oxidative stress responses and cancer cell growth. Part of these studies focus on analysis of non-canonical transcription regulatory functions of the TERC and Tert components of telomerase in lung disease and cancer.
-
Larissa Roux MD PhD
Adjunct Professor, Medicine - Primary Care and Population Health
BioLarissa Roux is a sport medicine physician and health economist. She completed medical school at the University of Alberta, and followed this with residency training in family medicine and a fellowship in primary care sport medicine at the University of Calgary, as well as advanced training in lifestyle medicine. She combined her clinical training with a master’s in public health at Harvard, and a PhD in health economics at the University of Calgary. Her interest in public health and health policy resulted in a post-doctoral fellowship at the US Centers for Disease Control, in Atlanta in the Division of Nutrition and Physical Activity. Although she has deeply enjoyed working with athletes and dancers, her main clinical interest has been in the optimization of human performance in patients with chronic conditions, including obesity, arthritis, and trauma. Her academic and health policy work has focused on the economic evaluation of competing therapies for obesity, and population-level physical activity promotion strategies in the US and around the world. Larissa's interest in data science and technology applications in global health contributed to an ongoing health information technology venture. She believes that innovative, tailored, multidisciplinary, and multimodal approaches to chronic disease have transformative potential in human health.
-
Corey Rovzar
Instructor, Medicine - Stanford Prevention Research Center
Current Research and Scholarly InterestsEnhancing human movement through scalable, remotely delivered physical activity interventions, remote assessment and monitoring of human movement, health technology development, fall prevention, aging, digital balance assessment, improving access to health and healthcare, increasing healthspan, lifestyle medicine
-
Mohana Roy, MD
Clinical Assistant Professor, Medicine - Oncology
BioDr. Roy is a medical oncologist and a clinical assistant professor in the Stanford University School of Medicine Department of Medicine, Division of Medical Oncology. She has expertise in Lung and Thoracic cancers, but with a broad clinical interest in oncology, including in Carcinoma of Unknown Primary (CUP).
Dr. Roy became an oncologist because of her passion for patient care. She is committed to being a clinician and is focused on improving the patient experience, given how the complex process of getting cancer care can be made a bit more seamless. She is the Associate Medical Director for Quality at Stanford Cancer Center from 2022.
She had led major efforts in the cancer program including starting standardized discharge follow up for patients after hospitalization, starting same day clinical care at the cancer center, and also expediting care for patients with an unclear diagnosis of cancer but with suspected imaging concerns.
Her research interests include access to clinical trials, quality improvement and improving care delivery. In that effort, she has published on work regarding patient reported outcomes (PROs), through distress screening with the Stanford Medicine Cancer Center, and in care for patient with limited English proficiency.
Dr. Roy received her medical degree from Albert Einstein College of Medicine, and then completed residency training at Beth Israel Deaconess Medical Center. She then completed fellowship training in Hematology and Oncology at Stanford, where she was chief fellow. -
Michael Royer
Postdoctoral Scholar, SCRDP/ Heart Disease Prevention
Current Research and Scholarly InterestsDr. Royer's research interests include food insecurity, eating behaviors, and physical activity. His research primarily aims to remove barriers hindering individuals from accessing healthy food. Dr. Royer seeks to advance public health by sustainably promoting healthy eating and food security through innovative and evidence-based research approaches. Through his research, he is motivated to promote food security, healthy eating, and physical activity toward the prevention of chronic disease.
-
Michael Rubin
Adjunct Professor, Medicine
BioMichael P. Rubin, MD, PhD is the Founder and CEO of Northpond Ventures, a multi-billion dollar science driven venture capital firm. Northpond is based in Cambridge, MA; San Francisco, CA; and Bethesda, MD. Dr. Rubin has been involved in investing in and developing over 100 startups, in a broad array of disciplines, including medicine, technology, financial services, and global consumer. Dr. Rubin’s experience spans engineering, medicine, surgery, venture capital, and entrepreneurship. Dr. Rubin also holds academic appointments at Harvard and MIT.
-
Peter Rudd, MD
Professor of Medicine (General Internal Medicine) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsQuality improvement efforts seek to make medical care the best it can be rather than merely good enough to avoid censure. Focus on improving the average performance usually produces more net benefit than eliminating outliers, often by simplification, standardization, and specification. We have worked with electronic medication monitors, clinical databases, and computerized order entry systems for better clinical outcomes and trained clinicians for professionalism and accountability.
-
Stephen Ruoss
Professor of Medicine (Pulmonary and Critical Care)
Current Research and Scholarly InterestsWe have an active collaborative project examining basic and clinical aspects of non-tuberculous mycobacterial lung infection in non-immune compromised adults. Studies have examined possible cellular immune mechanisms for increased susceptibility to these infections, and are also investigating aspects of optimal diagnosis and treatment. In addition, a clinical and translational research program is investigating the causes and genetic factors underlying the evolution of bronchiectasis.
-
Tracy Rydel
Clinical Professor, Medicine - Primary Care and Population Health
BioTracy Rydel is Clinical Professor of Medicine at Stanford University School of Medicine where she holds the positions of Assistant Dean for Clerkship Education and Director, Core Clerkship in Family and Community Medicine. She has also served as the Director of Medical Student Education in the Division of Primary Care and Population Health, and was an Educator-4-CARE faculty from 2017-2020. She is a family physician with a passion for medical education. She completed the Rathmann Family Foundation Fellowship in Patient-centered Care and Medical Education in 2012, was in the first wave of peer coaches in the Peer Coaching Program under the Stanford Teaching and Mentoring Academy, and was the Director of the Practice of Medicine Year One Course at Stanford from 2013-2016. She emphasizes patient-centered care in the pursuit of clinical and educational excellence. She is frequently an invited presenter at the national conferences of the Society of Teachers of Family Medicine (STFM), and the Western Group on Educational Affairs (WGEA) regional group of the AAMC; her scholarly work focuses on medical education endeavors, including equity and justice in systems of medical education assessment. She has also presented and published on topics in nutrition education and the teaching kitchen, working with medical scribes, Entrustable Professional Activities, primary care career recruitment and mentoring, procedures training, time management in ambulatory teaching, communication skills, virtual health and telehealth, teaching gender-affirming primary care, and learning communities.
-
Nojus Saad
Masters Student in Clinical Informatics Management, admitted Summer 2026
BioNojus Saad, MD, is a physician-entrepreneur and digital health diplomat dedicated to engineering health justice through scalable digital systems. As a Technical Advisor to the World Health Organization (WHO), he co-develops global adolescent health indicators adopted by the World Bank, UNFPA, and UN H6+ Partners. His leadership in rural and LMIC communities across Iraq, India, and France is anchored by his role as Founder of the Youth For Women Foundation, where he has spearheaded 45 youth-led initiatives directly impacting the lives of 18,500 women and young people.
Dr. Saad’s diplomatic expertise spans health and security, serving as UN Youth Ambassador for Disarmament and Biosecurity (UNODA) and as the MENA Youth Lead for the Swiss-based DTH-Lab. Through these mandates, he has mobilized coalitions across 12 MENA countries to integrate digital innovation into national health agendas. This high-level advocacy is validated by his track record as a systems architect; in 2021, he orchestrated a digital health literacy and COVID-19 misinformation initiative for rural and displaced populations. By building the digital capacity of NGO leaders and youth, he empowered grassroots networks to execute 15 targeted awareness campaigns, reaching 10,000 women and youth to strengthen their access to reliable health services.
Currently, Dr. Saad is scaling this success into a coordinated, all-in-one digital platform that bridges Iraq’s public and private healthcare sectors. By implementing interoperable EHRs and data-driven matching, his startup digitizes the entire referral pathway to connect Iraqi patients with the most cost-effective, high-quality care providers both domestically and abroad in the U.S. and France. This venture transforms fragmented systems into a seamless, unified framework for optimized clinical access and specialist care.
A Knight-Hennessy Scholar and advisor to Lady Gaga’s Born This Way Foundation, Dr. Saad holds an MD with executive diplomatic training from the Karolinska Institute and Stockholm School of Economics. At Stanford MCiM, he is refining the technical and managerial frameworks necessary to lead the next generation of inclusive, tech-driven health systems in LMICs. -
Agustina D Saenz
Clinical Assistant Professor, Medicine
BioAgustina Saenz is a Clinical Assistant Professor in the Division of Hospital Medicine at Stanford University School of Medicine. She earned her medical degree from the Universidad de Buenos Aires and completed her internal medicine residency, and later served as Chief Resident at Einstein Medical Center. She further pursued graduate studies at Harvard, earning a Master in Public Health from the T.H. Chan School of Public Health and a Master in Biomedical Informatics from Harvard Medical School. She also completed a Clinical Informatics fellowship at Mass General Brigham prior to joining the Stanford faculty.
Dr. Saenz’s work bridges clinical care, AI research, and health system operations. At Curai Health, she serves as a Senior Clinical Informaticist, focusing on optimizing large language models to improve diagnostic reasoning and patient safety. Her academic interests include the responsible deployment of AI in healthcare, evaluation of model generalizability, and developing system-level interventions to advance health equity. Prior to her current role, she served as Unit Medical Director and Chair of the Hiring Committee at Brigham and Women’s Hospital, where she led initiatives to enhance quality metrics and foster inclusive hiring practices. -
Heidi Salisbury
Affiliate, Medicine - Med/Cardiovascular Medicine
BioHeide Salisbury, CNS is a clinical nurse specialist who works at the Stanford Heart Failure and Cardiomyopathy Clinic.
-
Karim Sallam, MD
Assistant Professor of Medicine (Cardiovascular Medicine)
BioKarim Sallam, MD, is trained in Cardiovascular Medicine and Advanced Heart Failure.
-
Arghavan Salles
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
BioDr. Salles is a minimally invasive and bariatric surgeon. She completed medical school and residency in general surgery at Stanford prior to completing her fellowship in minimally invasive surgery at Washington University in St. Louis. She stayed on faculty at Washington University for three years prior to moving back to Stanford in 2019.During the pandemic, Dr. Salles has served as a disaster relief physician, caring for patients with COVID in the ICU. Dr. Salles obtained a PhD in education from Stanford University during her residency training, and her research focuses on gender equity, implicit bias, diversity, inclusion, and physician well-being. Her R01 grant from the NIH focuses on sexual harassment. She is a sought-after speaker and has given over 100 national and international invited talks related to gender equity, physician well-being, and weight bias. She currently serves as the Special Advisor for DEI Programs at the Stanford University Department of Medicine where she is a Clinical Associate Professor.
-
Giselle (Ghazal) Salmasi, MD
Clinical Associate Professor, Medicine - Hematology
BioDr. Salmasi is a board-certified, fellowship-trained hematologist. She treats patients in the Hematology Program and the Hematologic Cancer Program at Stanford Health Care. Dr. Salmasi is the associate clinical chief for classical hematology. She is also a clinical associate professor in the Division of Hematology, Department of Medicine at Stanford University School of Medicine.
She treats a wide range of blood disorders and blood cancers. Her clinical/research interests include immune thrombocytopenia (ITP) and warm autoimmune hemolytic anemia (wAIHA). Dr. Salmasi understands that patients need social and emotional support along with medical care. She founded the earliest adolescent and young adult survivorship support groups in Santa Cruz, California, and Toronto, Canada. Dr. Salmasi is also dedicated to training future doctors in providing excellent hematologic care.
Dr. Salmasi was the medical co-investigator for a national phase 3 clinical trial of endovascular therapy for treating chronic venous thrombosis.
Her research has appeared in the New England Journal of Medicine, Leukemia & Lymphoma journal and the Transfusion and Apheresis Science journal. Dr. Salmasi’s publications include articles and a chapter about lymphoma. She has also reviewed articles for the Biology of Blood and Marrow Transplantation journal and the Journal of Clinical Oncology.
Dr. Salmasi is a member of the American Society of Hematology. -
Alexander Isaac Salter
Affiliate, Department Funds
Fellow in Medicine - Med/HematologyBioI am a clinical fellow in medical oncology at Stanford University whose long-term goal is to become a translational physician-scientist who develops curative cellular immunotherapies for solid tumors. As a graduate student, I conducted the first comprehensive signaling analyses of therapeutically engineered T cells, demonstrating that signal strength, rather than quality, is a key determinant of T cell function and fate. These findings helped inform the design of next-generation cellular immunotherapies, some of which are now in clinical trials. I also co-led a collaboration with Dr. David Baker’s laboratory at the University of Washington to engineer synthetic protein “logic gates” enabling combinatorial antigen recognition with high precision, offering a potential path to more safely target solid tumors. My doctoral research resulted in 16 publications, including four prominent first-, co-first-, or second-author papers in high-impact journals, several reviews and textbook chapters, and recognition on the Forbes 30 Under 30 List.
At Stanford, I focus on translating cellular therapies for thoracic and genitourinary malignancies. Under the mentorship of Drs. Crystal Mackall and Allison Betof Warner, I am developing CAR T cells for lung cancer in non- and never-smokers and serve as a sub-investigator on an upcoming first-in-human phase 1 trial of drug-regulatable CAR T cells for adults with advanced solid tumors. -
Fabian Sanchis Gomar
Visiting Instructor, Medicine - Med/Cardiovascular Medicine
BioDr. Fabián Sanchis Gomar (M.D., Ph.D.) has published more than 345 manuscripts in international peer-reviewed journals related to several topics, wide-ranging in cardiology, arrhythmias, aging, exercise, and oxidative stress. His most relevant works have been based on the molecular and physiopathological mechanisms implicated in various diseases and identifying potential novel mechanisms and biomarkers associated with those diseases' pathogenesis.
As a dedicated researcher in the field of arrhythmias and sports cardiology, his journey has been driven by a deep-seated passion for unraveling the complexities of the heart, particularly in the context of athletic performance. His fascination with the heart's rhythm and how it adapts to the extreme demands of sports began early in his career as a medical student, where he was captivated by the intricate balance between physical excellence and cardiac health.
Throughout his years in academia and research, Dr. Sanchis-Gomar has been privileged to work at the forefront of sports cardiology, a field that sits at the fascinating intersection of cardiology and sports medicine. His postdoc research focused on the pathophysiology of arrhythmias in elite athletes, shedding light on how intense physical training can alter cardiac function and rhythm. This work laid the foundation for his subsequent research endeavors, which have been dedicated to understanding and preventing sports-related cardiac events.
One of the core objectives of his research has been to develop effective strategies for the early detection and management of arrhythmias in athletes. This pursuit has been academically fulfilling and deeply personal, as it stems from witnessing athletes face unexpected cardiac challenges. Another aspect of his career that he holds in high regard is his role in educating and mentoring the next generation of researchers. He firmly believes that the future of the field hinges on the enthusiastic and informed involvement of young professionals, and he takes great pride in sharing his knowledge and experiences with them.
Community engagement has also been a key component of his career. He has actively participated in numerous outreach programs to raise awareness about athlete heart health. These programs disseminate information and build a community of athletes, coaches, trainers, and healthcare professionals who are informed, vigilant, and proactive about cardiac health in sports.
As he looks to the future, he is excited by the endless possibilities in sports cardiology. The rapid advancements in technology and medicine promise new avenues for research and clinical application. He aims to continue contributing to this dynamic field by advancing scientific understanding and ensuring that this knowledge translates into better care and safer sports participation for athletes at all levels. -
Alexander Tarlochan Singh Sandhu
Affiliate, Med/Center for Digital Health (CDH)
BioAlex Sandhu, MD, MS is a cardiologist with a special interest in the care of patients with advanced heart failure. He graduated from the seven-year combined BA-MD program at Northwestern with a focus on economics and mathematics. He completed an internal medicine residency at Stanford University, spending 16 weeks at Makerere Hospital in Uganda as part of the Global Health track. He subsequently earned a Masters in Health Services Research at Stanford while acting as a fellow in health services research at the Palo Alto VA and Stanford's Center for Health Policy/Primary Care and Outcomes Research. Next, he completed fellowships in cardiology and advanced heart failure and transplant at Stanford before joining the faculty as an Assistant Professor in Stanford Cardiology and the Stanford Prevention Research Center.
Alex is now an active clinician and clinical researcher who focuses on the implementation of high-value preventive strategies, comparative effectiveness, innovative clinical trial design, and health economics. He is passionate about testing patient-centered implementation strategies to bring meaningful improvements to patients’ lives and prevent disease morbidity. He is involved in several clinical trials including the K-23 funded PRO-HF (patient-centered quality of life assessments), DOT-HF (digital health study for HF patient activation), a CAC notification pilot trial (patient-centered coronary artery calcification notification), and PHARM-HF (testing strategies to improve HF management by pharmacists).
In his free time, he enjoys playing soccer as well as entertaining and being entertained by his joyful kids, Kyle, Tyler, and Kira. -
Sunny Sandhu, MD
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr. Sunny Sandhu is a board-certified, fellowship-trained transplant hepatologist at Stanford Health Care. He also serves as a clinical assistant professor in the Department of Medicine, Division of Gastroenterology & Hepatology at Stanford University School of Medicine.
Dr. Sandhu specializes in managing all aspects of liver disease. He has a particular focus on cirrhosis, liver transplantation, and outreach programs to improve access to care for patients with advanced liver disease.
Dr. Sandhu’s research focuses on chronic liver diseases and liver transplantation. He has published on various topics including the management of end-stage liver disease and its associated complications, liver transplantation, and organ allocation. He has presented his work at national meetings and contributed to multiple peer-reviewed journals and book chapters in the field.
Dr. Sandhu is a fellow of the American College of Physicians (ACP) and a member of the American Association for the Study of Liver Diseases (AASLD), American Society of Transplantation (AST), American College of Gastroenterology (ACG), American Society for Gastrointestinal Endoscopy (ASGE), and American Gastroenterological Association (AGA). -
Ryan Sandoval, M.D.
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Sandoval is a board-certified cardiologist and a clinical assistant professor in the Division of Cardiovascular Medicine at Stanford University School of Medicine. He completed his residency at the University of Texas at Austin, where he continued on as chief resident before going on to complete his fellowship in cardiovascular disease at the Medical University of South Carolina. Prior to his residency, he completed a research fellowship at Massachusetts General Hospital (MGH).
His clinical interests include preventive cardiology and management of heart failure. He is particularly focused on treating patients with the complex clinical syndrome of heart failure with preserved ejection fraction (HFpEF).
His interest in preventive cardiology grew through his participation in clinics for the uninsured and underinsured during his training. These experiences fostered his passion for understanding and addressing health care disparities. He is deeply committed to providing exceptional patient care with a personalized approach to treatment and improving the lives of his patients.
He is a member of the American College of Cardiology. -
Alejandro Sandoval Lentisco
Postdoctoral Scholar, SCRDP/ Heart Disease Prevention
BioAlejandro completed his PhD in Psychology at the University of Murcia, Spain, in 2024. His doctoral research focused on assessing transparency and risk of bias in psychology meta-analyses. Prior to this, he obtained an MSc in Cognitive and Behavioral Neuroscience from the University of Granada, Spain. In addition to evaluating methodological practices in evidence synthesis and empirical studies, he is interested in a wide range of meta-scientific questions, such as how science self-corrects and how research should be evaluated.
-
Rebecca Sands
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Sands currently serves as the Clinical Section Chief of Palliative Care at Stanford University, where she directly supervises 13 physicians and oversees the inpatient and outpatient clinical programs at Stanford Health Care. She graduated from Franklin & Marshall College in 2001 with a BA in Chemistry. She then attended Midwestern University, Chicago College of Osteopathic Medicine from 2002-2006. She completed a residency and chief residency in Internal Medicine at Cambridge Health Alliance, a public teaching hospital of Harvard Medical School. She went on to complete her Hospice and Palliative Medicine (HPM) fellowship at the Harvard combined program at Massachusetts General Hospital/Dana Farber Cancer Institute in 2011. She spent 8 years at the University of Pittsburgh where she served as core teaching faculty and the HPM Fellowship Program Director. Since her recruitment to Stanford, her focus has been on programmatic expansion of clinical Palliative Care services across healthcare settings and throughout the trajectory of the serious illness experience. This has included recruitment of dually boarded faculty, development of an Emergency Palliative Care program, and many other new and innovative initiatives.
-
Gerald Sarkes
Clinical Research Coordinator, Medicine - Primary Care and Population Health
Current Role at StanfordClinical Research Coordinator
-
Varsha Sivagami Sathappan
Clinical Assistant Professor, Medicine
BioDr. Varsha Sathappan is a hospitalist and Clinical Assistant Professor at Stanford University School of Medicine. She earned her M.D. from Baylor College of Medicine and completed her Internal Medicine residency at UC San Diego, where she pursued the Clinician Educator pathway. Her clinical interests include transitions of care and health equity. She is also passionate about medical education and curriculum development.
-
Anuja Anand Sathe
Instructor, Medicine - Oncology
Current Research and Scholarly InterestsI am interested in understanding the determinants of therapeutic resistance in cancer. I investigate the composition of the tumor microenvironment and adaptive responses to therapy using single-cell and spatial approaches.
-
Neda Sattarnezhad Oskouei, MD, MS
Instructor, Medicine - Immunology & Rheumatology
BioDr. Neda Sattarnezhad Oskouei is a board-certified neurologist and neuroimmunologist specializing in Multiple Sclerosis (MS) and neuroimmunological disorders, including Neuromyelitis Optica (NMO), MOG Antibody Disease (MOGAD), optic neuritis, transverse myelitis, autoimmune encephalitis, neuro-rheumatological conditions, and neuroinfectious diseases. Her research focuses on understanding the role of pathogens in triggering autoimmunity, with a particular emphasis on the role of Epstein-Barr Virus (EBV) in the development of MS.
Dr. Sattarnezhad earned her MD degree with honors from Tabriz University of Medical Sciences. She completed a research fellowship in Multiple Sclerosis at the Brigham MS Center, Harvard Medical School, before pursuing her residency in adult neurology at the University of Illinois at Chicago. She further specialized by completing a clinical fellowship in Multiple Sclerosis and Neuroimmunology at Stanford University as a Sylvia Lawry Fellow of the National MS Society, during which she also earned a master’s degree in Epidemiology and Clinical Research. She subsequently completed a fellowship in immunology and rheumatology at Stanford.
Her research and training have been supported by the National MS Society (NMSS), National Institutes of Health (NIH), and National Institute of Allergy and Infectious Diseases (NIAID). -
Amelia Sattler, MD
Clinical Associate Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsCurrently working on projects identifying effective use of actual patient encounters in undergraduate medical education. Specifically interested in the role of actual patient encounters in the training of shared decision making. Also interested in medical student empathy and physician wellness.
Also working on many different projects in the realm of quality improvement and population health in the Division of Primary Care and Population Health. -
Anjali Bhatt Saxena, MD FASN
Clinical Professor (Affiliated), Medicine - Med/Nephrology
BioDr. Anjali Bhatt Saxena, MD is a Clinical Professor of Medicine (Affiliated) at Stanford University School of Medicine and the Director of Peritoneal Dialysis at the Santa Clara Valley Medical Center in San Jose, California. She has served as the Medical Director for an independent Peritoneal Dialysis (PD) Clinic in San Jose, CA since 2004, overseeing a large Peritoneal Dialysis clinic.
Dr. Saxena's clinical and research interests are in the area of home dialysis, including Peritoneal Dialysis and Home Hemodialysis. She is devoted to sharing her home dialysis expertise through research and education worldwide. She has been a key faculty member of Home Dialysis University (HDU) since 2007, providing home dialysis education to hundreds of US Nephrology Fellows and Nephrologists at all levels of experience; in 2024 she became HDU Program Director. She serves on the ASN Home Dialysis Steering Committee and is a founding member of the International Home Dialysis Consortium (ISN-ISPD). She has delivered numerous invited lectures at international meetings and has published scholarly work on PD in various peer-reviewed journals. Dr. Saxena is dedicated to the growth of PD worldwide; she is the immediate past-Treasurer for the International Society for Peritoneal Dialysis (ISPD) and Past-President of the N. American Chapter of ISPD. She is an Educational Ambassador for the ISN, and with colleagues supported the growth of PD in low income areas of Sri Lanka. -
John Scandling
Professor of Medicine (Nephrology) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsTolerance induction in clinical kidney transplantation
-
Lidia Schapira
Professor of Medicine (Oncology)
BioDr. Schapira is a medical oncologist with clinical expertise in the treatment of breast cancer. As the inaugural Director of Stanford's Cancer Survivorship Program, she has developed a thriving research and clinical program focused on optimizing health outcomes for people living with and beyond cancer. Dr. Schapira is interested in training future generations of physician-scientists as well as the broader community of practicing physicians through the design of innovative educational programs. Dr. Schapira's advocacy for people with cancer led to her appointment as Editor-in-Chief of the American Society of Clinical Oncology's website for the public,Cancer.Net, a position she held from 2015 until-2021. She served on the Board of Directors of the American Psychosocial Oncology Society and as Chair of the Psychosocial Interest Group of the Multinational Society for Supportive Care in Cancer. Dr. Schapira is particularily committed to reducing inequities in cancer outcomes and improve access to cancer care and cancer clinical trials. Dr. Schapira has published numerous manuscripts, lectures both nationally and internationally on issues of cancer survivorship and served as Associate Editor of the narrative section, Art of Oncology, for the Journal of Clinical Oncology from 2013 until 2023.
-
David Scheinker
Clinical Professor, Pediatrics - Endocrinology
Clinical Professor, MedicineBioDavid Scheinker is the Executive Director of Systems Design and Collaborative Research at the Stanford Lucile Packard Children's Hospital. He is the Founder and Director of SURF Stanford Medicine, a group that brings together students and faculty from the university with physicians, nurses, and administrators from the hospitals. SURF has implemented and published dozens of projects demonstrating improvements to the quality and efficiency of care. His areas of focus include clinical care delivery, technical improvements to hospital operations, sensor-based and algorithm-enabled telemedicine, and the socioeconomic factors that shape healthcare cost and quality.
Before coming to Stanford, he was a Joint Research Fellow at The MIT Sloan School of Management and Massachusetts General Hospital. He received a PhD in theoretical math from The University of California San Diego under Jim Agler. He advises Carta Healthcare, a healthcare analytics company started by former students. -
Erika Schillinger
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsMy passion is clinical skills education: the patient's experience of health and healthcare, doctor-patient communication, professionalism and physical exam. I am focused on curriculum design and innovation, having helped develop the Continuity of Care Clerkship, the clinical skills curriculum in Practice of Medicine, the Family Medicine core clerkship, outpatient faculty development modules and the SHIELD course (Stanford Healthcare Innovations and Experiential Learning Directive).
-
Ingela Schnittger, MD
Professor of Medicine (Cardiovascular)
Current Research and Scholarly InterestsMy main research continues to be in the field of echocardiography. Several areas of research are currently being pursued.
-
Gary Schoolnik
Professor of Medicine (Infectious Diseases), Emeritus
Current Research and Scholarly InterestsStructure-function analysis of bacterial adhesion proteins and toxins; design and synthesis of synthetic antigens; immunobiology of human papillomaviruses
-
John S. Schroeder, MD
Professor (Clinical) of Medicine (Cardiovascular), Emeritus
Current Research and Scholarly Interests1. Clinical Pharmocology of Cardiovascular Drugs
(a) Calcium Channel Blockers
(b) Agents for Heart Failure
(c) Anti-atherosclerotic Effects of Cardiovascular Drugs, e.g. Calcium Channel Blockers
2. Cardiac Transplantation/Congestive Heart Failure
3. Coronary Artery Spasm -
Joseph Schroers-Martin
Assistant Professor of Medicine (Oncology)
Current Research and Scholarly InterestsMedical heme/onc focused on molecular cancer diagnostics and novel biomarkers.
-
Kevin Schulman
Professor of Medicine (Hospital Medicine), by courtesy, of Health Policy and of Operations, Information and Technology at the Graduate School of Business
BioDr. Schulman is a Professor of Medicine, and, by courtesy, Professor of Operations, Information and Technology at Stanford’s Graduate School of Business. He serves as an Associate Chair of the Department of Medicine. He is the Faculty Director of Stanford’s new applied master degree program, the Master of Science in Clinical Informatics Management program. He also serves as Deputy Director of the Clinical Excellence Research Center (CERC) at the Stanford University School of Medicine, and has an appointment in the Department of Health Policy (by courtesy).
Dr. Schulman is a health economist/health services researcher working at the intersection of business, medicine and technology. With over 500 publications, he has had a broad impact on several areas of health policy (Scopus h-index=83). His research has appeared in the New England Journal of Medicine, the Journal of the American Medical Association, and Health Affairs. He is the editor-in-chief of Health Management, Policy and Innovation (www.HMPI.Org), and Senior Associate Editor of Health Service Research (HSR).
He is a graduate of Dartmouth College, the New York University School of Medicine, and The Wharton Health Care Management Program. He is an elected member of ASCI and AAP.
